BE THE NEW

Treasury Senior Manager

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines


We are looking for a new Treasury Senior Manager, who will play a key role in our Finance organization. This is a unique opportunity to lead the treasury function for Zealand Pharma, a C25 listed biotech company (Nasdaq Copenhagen: ZEAL), who has successfully managed to raise substantial capital these last years, of which recently DKK 7 billion in June 2024 (largest ever Nordic biotech, and largest ever European biotech capital raise with development stage funding).

If you have a passion for investment and cash flow management, and you are ready to take on a broad area of responsibilities with an independent attitude,
we want to bond with you.

The position reports to the VP Finance & Accounting. You will be working out of Zealand Pharma’s group offices in Søborg, Denmark.

Responsibilities

Strategic Treasury Management:
Cash Flow Management:
Bank and External Relationship Management:
Risk Management and Compliance:
Operational Management, Reporting & Analysis:
Finance transformation:

Candidate profile

The Treasury Senior Manager will be responsible for developing and executing the company's treasury strategy and optimizing liquidity across our global operations. This role requires a strategic leader who is also hands-on, with the ability to navigate complex financial markets and contribute to the overall financial health of the company. The Treasury Senior Manager will play a pivotal role in risk management, cash flow forecasting, and capital allocation. This know-how will have been gained through a similar experience in an international corporation.

Attitude is as important as functional skills, the candidate will be displaying a humble, service minded ‘can do’ attitude, be a team player, and will be living up our Zealand Pharma’s DNA and values. The candidate will furthermore be comfortable with change, working as part of the team to improve processes and systems in the organization, with the knowledge of “what goods looks like” in the field of treasury.

Qualifications

Bonding to innovate

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.

Making bonds is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with our partners or connecting with each other.

We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We bond by being curious about each other’s knowledge and expertise.

We bond through playfulness as a team, allowing ourselves to challenge common thinking, sowing the seeds of future innovation. We bond by making Zealand Pharma a place where everyone is heard and contributes to the success, we all want to experience.

The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.

Let’s bond and be bold

We offer a combined compensation package which includes a base salary, pension, bonus, and an attractive employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities.

To find out more about working at Zealand, visit our career site.

Interested? Please apply as soon as possible and no later than September 27, 2024. The applications will be reviewed as they come in.

If you have any questions, please reach out to Vice President, Joseph Chemali on JChemali@zealandpharma.com


About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.



Stillingen er ikke aktiv og kan ikke søges